Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Sundsvall
Clinical trial register · Sweden

Clinical Trials in Sundsvall, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Sundsvall

25 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Sahlgrenska University Hospital
Phase 4
216
Malmö, Huddinge, Stockholm, Uppsala, Umeå, Sundsvall, Mölndal, Skövde
2027-01-11
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study
NCT07797374Postoperative Nausea and Vomiting, Postoperative Pain, Obesity, Morbid, Bariatric Surgery
Umeå University
Observational
30,000
Sundsvall, Umeå
2025-10-01
Recruiting
The Intensive Care Platform Trial
NCT06667999Intensive Care Patients, Intensive Care Unit Patients, Critical Illness
Anders Perner
Phase 4
10,000
Stockholm, Malmö, Sundsvall
2025-06-26
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma
Vastra Gotaland Region
Phase 3
200
Gävle, Gothenburg, Jönköping, Kalmar, Lund, Örebro, Stockholm, Sundsvall
2025-02-01
Recruiting
Umeå University
Not applicable
176
Falun, Östersund, Södra Sunderbyn, Karlstad, Umeå, Sundsvall, Örebro
2024-11-20
Active, closed
Novo Nordisk A/S
Phase 4
500
Falun, Halmstad, Malmö, Sundsvall, Uppsala
2024-09-17
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Danderyd, Gothenburg, Linköping, Lund, Stockholm, Sundsvall, Uppsala
2024-08-30
Active, closed
The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction
NCT06262815Small Bowel Obstruction, Frailty, Nasogastric Tube
Daniel Wilhelms
Observational
400
Gothenburg, Lund, Malmö, Motala, Norrköping, Sundsvall, Linköping
2024-01-01
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
Recruiting
Ersta Diakoni
Not applicable
124
Gothenburg, Lund, Nyköping, Stockholm, Sundsvall, Uppsala
2023-06-01
Recruiting
Karolinska Institutet
Not applicable
712
Stockholm, Gothenburg, Lidköping, Sundsvall, Umeå, Västerås
2022-11-09
Recruiting
Strategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis
NCT05817747Constriction, Pathologic, Spine Degeneration, Surgery, Radiculopathy
Sahlgrenska University Hospital
Not applicable
900
Ängelholm, Malmö, Gothenburg, Stockholm, Sundsvall, Umeå, Uppsala
2022-03-01
Active, closed
Tampere University Hospital
Not applicable
240
Danderyd, Sundsvall
2021-12-01
Recruiting
Alexander Valdman
Not applicable
254
Stockholm, Gävle, Gothenburg, Linköping, Lund, Sundsvall, Umeå, Uppsala
2021-04-20
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
NCT03903835Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Karolinska Institutet
Phase 3
750
Falun, Borås, Jönköping, Kalmar, Karlstad, Örebro, Stockholm, Sundsvall
2019-02-01
By invitation
Helsinki University Central Hospital
Observational
200
Lund, Stockholm, Sundsvall, Uppsala
2018-06-01
Active, closed
Eli Lilly and Company
Phase 3
5,637
Malmö, Umeå, Sundsvall, Västerås, Vaxjo
2017-07-12
Active, closed
Uppsala University
Not applicable
2,008
Gothenburg, Linköping, Luleå, Örebro, Sundsvall, Umeå, Uppsala, Vaxjo
2016-10-03
Recruiting
Pain and Nausea After Gallbladder Surgery
NCT06083558PONV, Postoperative Pain, Postoperative Complications, Gall Bladder Disease
Umeå University
Observational
50,000
Sundsvall
2016-01-01
Recruiting
Early PONV - a Registry Based Study in Sweden.
NCT04433676Postoperative Nausea and Vomiting, Postoperative Complications
Jakob Wallden
Observational
1,500,000
Sundsvall
2016-01-01
Active, closed
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
Thomas Hatschek
Phase 2/3
202
Örebro, Gothenburg, Lund, Stockholm, Sundsvall, Umeå, Uppsala
2014-11
Active, closed
Trial on Three Treatments for Scoliosis
NCT01761305Idiopathic Scoliosis
Karolinska Institutet
Not applicable
135
Eskilstuna, Jönköping, Linköping, Stockholm, Sundsvall, Umeå, Västerås
2013-01
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/sundsvall

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Sundsvall.

How many clinical trials are recruiting in Sundsvall?

13 of the 25 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 10 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sundsvall), 25 studies
PhaseStudiesRecruitingShare
Not applicable8532%
Observational6424%
Phase 36224%
Phase 44216%
Phase 2/3104%

Most active sponsors

Lead sponsors with the most studies (Sundsvall)
Lead sponsorStudiesRecruiting
Karolinska Institutet32
Umeå University33
Sahlgrenska University Hospital21
Uppsala University21
Alexander Valdman11
Anders Perner11
AstraZeneca10
Boehringer Ingelheim10
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company11
Daniel Wilhelms10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.